Cargando…

Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma

Golgi protein 73 (GP73) is a resident Golgi type II transmembrane protein that has been reported to markedly increase in chronic liver disease, particularly in hepatocellular carcinoma (HCC). However, it remains unclear as to whether serum GP73 represents a reliable serum marker for the diagnosis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	HOU, SI-CONG, XIAO, MING-BING, NI, RUN-ZHOU, NI, WEN-KAI, JIANG, FENG, LI, XIAO-YAN, LU, CUI-HUA, CHEN, BU-YOU
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796428/ https://www.ncbi.nlm.nih.gov/pubmed/24137480 http://dx.doi.org/10.3892/ol.2013.1522

Ejemplares similares

GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells
por: Liu, Yujuan, et al.
Publicado: (2021)

A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma
por: Pang, Bing-yao, et al.
Publicado: (2022)

Magnetic Resonance Imaging and Serum AFP-L3 and GP-73 in the Diagnosis of Primary Liver Cancer
por: Yuan, Jun-Jian, et al.
Publicado: (2022)

The Value of MRI Combined with AFP, AFP-L3, GP73, and DCP in the Diagnosis of Early Primary Liver Cancer
por: Kang, Zhongjing, et al.
Publicado: (2022)

Retracted: The Value of MRI Combined with AFP, AFP-L3, GP73, and DCP in the Diagnosis of Early Primary Liver Cancer
por: Markers, Disease
Publicado: (2023)

Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma
por: Ke, Meng-yun, et al.
Publicado: (2019)

Efficacy of Sorafenib Combined with Interventional Therapy on Primary Liver Cancer Patients and Its Effect on Serum AFP, VEGF, and GGT
por: Jia, Ying, et al.
Publicado: (2021)

Diagnostic Value of Multislice Spiral Computed Tomography Combined with Serum AFP, TSGF, and GP73 Assay in the Diagnosis of Primary Liver Cancer
por: Yu, Chuanwen, et al.
Publicado: (2022)

GP73 level determines chemotherapeutic resistance in human hepatocellular carcinoma cells
por: Ye, Jia-Zhou, et al.
Publicado: (2018)

TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma
por: Mao, Liping, et al.
Publicado: (2017)

Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma
por: ZHU, JING, et al.
Publicado: (2013)

Combined preoperative albumin-bilirubin (ALBI) and serum γ-glutamyl transpeptidase (GGT) predicts the outcome of hepatocellular carcinoma patients following hepatic resection
por: Zhang, Chi-Hao, et al.
Publicado: (2019)

Serum GGT/ALT ratio predicts vascular invasion in HBV-related HCC
por: Zhao, Zhifeng, et al.
Publicado: (2021)

Serum GGT and serum ferritin as early markers for metabolic syndrome
por: Mohapatra, Eli, et al.
Publicado: (2020)

Expression and prognostic significance of Golgiglycoprotein73 (GP73) with Epithelial-mesenchymal transition (EMT) related molecules in Hepatocellular Carcinoma (HCC)
por: Bao, Yong xing, et al.
Publicado: (2013)

Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
por: Park, Sang Joon, et al.
Publicado: (2017)

Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
por: Ren, Tianying, et al.
Publicado: (2023)

The diagnostic value of PIVKA‐II, AFP, AFP‐L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma
por: Qi, Famei, et al.
Publicado: (2019)

A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
por: Yu, Wei-Ming, et al.
Publicado: (2023)

Serum GP73, a Marker for Evaluating Progression in Patients with Chronic HBV Infections
por: Wei, Hongshan, et al.
Publicado: (2013)

Clinical value of serum AFP and PIVKA‐II for diagnosis, treatment and prognosis of hepatocellular carcinoma
por: Tian, Shan, et al.
Publicado: (2022)

Identification of Plasma hsa_circ_0005397 and Combined With Serum AFP, AFP-L3 as Potential Biomarkers for Hepatocellular Carcinoma
por: Liu, Ruoyu, et al.
Publicado: (2021)

Serum Golgi Protein 73 (GP73) is a Diagnostic and Prognostic Marker of Chronic HBV Liver Disease
por: Xu, Zhengju, et al.
Publicado: (2015)

Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer
por: Loosen, Sven H., et al.
Publicado: (2022)

Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP
por: Wang, Ya-Kun, et al.
Publicado: (2018)

Value of serum GGT level in the timing of diagnosis of choledochal cyst perforation
por: Zhang, Shuhao, et al.
Publicado: (2022)

c-Myc transactivates GP73 and promotes metastasis of hepatocellular carcinoma cells through GP73-mediated MMP-7 trafficking in a mildly hypoxic microenvironment
por: Liu, Yiming, et al.
Publicado: (2019)

The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients
por: Xu, Fei, et al.
Publicado: (2021)

Value of AFP and PIVKA-II in diagnosis of HBV-related hepatocellular carcinoma and prediction of vascular invasion and tumor differentiation
por: Si, Yuan-Quan, et al.
Publicado: (2020)

Simple Clinical Metrics Enhance AFP to Effectively Identify Cirrhotic Patients With Complicating Hepatocellular Carcinoma at Various AFP Levels
por: Zhang, Xi, et al.
Publicado: (2020)

Serum AFU, 5’-NT and AFP as Biomarkers for Primary Hepatocellular Carcinoma Diagnosis
por: Junna, Zhu, et al.
Publicado: (2017)

Research progress on GP73 in malignant tumors
por: Liang, Rong, et al.
Publicado: (2018)

Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray
por: Wu, Min, et al.
Publicado: (2018)

Epithelium-Specific ETS (ESE)-1 upregulated GP73 expression in hepatocellular carcinoma cells
por: Wang, Fang, et al.
Publicado: (2014)

GP73 N-glycosylation at Asn144 reduces hepatocellular carcinoma cell motility and invasiveness
por: Jiang, Kai, et al.
Publicado: (2016)

Alcohol, metabolic risk and elevated serum gamma-glutamyl transferase (GGT) in Indigenous Australians
por: Haren, Matthew T, et al.
Publicado: (2010)

Serum Gamma Glutamyltransferase (GGT) in Coronary Artery Disease: Exploring the Asian Indian Connection
por: Singh, Kunal K., et al.
Publicado: (2022)

Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases
por: Wang, Ting, et al.
Publicado: (2017)

Multiplexed Proteomic Approach for Identification of Serum Biomarkers in Hepatocellular Carcinoma Patients with Normal AFP
por: Lee, Young-Sun, et al.
Publicado: (2020)

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease
por: Beale, Gary, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_1l2opvm8l7o02thhr0tk6gunlk